Sales rise 3.13% to Rs 16.49 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 3.75 crore in the quarter ended September 2016 as against net loss of Rs 2.41 crore during the previous quarter ended September 2015. Sales rose 3.13% to Rs 16.49 crore in the quarter ended September 2016 as against Rs 15.99 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales16.4915.99 3 OPM %1.218.76 -PBDT-2.78-1.64 -70 PBT-3.80-2.17 -75 NP-3.75-2.41 -56Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
